Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 4/20 | 0.51 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.42 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.42 |
| ▸ | ACACB | O00763 | 9/20 | 0.41 |
| ▸ | AKT2 | P31751 | 4/20 | 0.41 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.40 |
| ▸ | KIT | P10721 | 1/20 | 0.40 |
| ▸ | GSK3B | P49841 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9049074 | 0.85 | AKT1 (0.54) | AKT1DOT1LHRH4AKT2LRRK2 | |
| SCHEMBL9048311 | 0.75 | AKT1 (0.47) | AKT1DOT1LHRH4AKT2LRRK2 | |
| SCHEMBL14599443 | 0.74 | ENPP1 (0.67) | — | |
| SCHEMBL9046030 | 0.74 | HTR2C (0.44) | — | |
| SCHEMBL16190458 | 0.69 | ACACB (0.49) | ACACB | |
| SCHEMBL14275566 | 0.69 | AKT1 (0.52) | AKT1DOT1LHRH4AKT2KIT | |
| SCHEMBL29364150 | 0.67 | AKT1 (0.50) | AKT1DOT1LHRH4AKT2 | |
| SCHEMBL23599086 | 0.67 | NPC1 (0.63) | AKT1DOT1LHRH4AKT2 | |
| SCHEMBL15178732 | 0.67 | DOT1L (0.85) | DOT1LAKT2KITGSK3B | |
| SCHEMBL10074309 | 0.67 | DOT1L (0.85) | DOT1LAKT2KITGSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0714896-A1 | INDOL DERIVATIVES USEFUL FOR THE TREATMENT OF MIGRAINE, COMPOSITION AND UTILIZATION | VITA-INVEST, S.A. (ES) | 1996-06-05 | — | — | EP | disclosed |